- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01566214
Vet-Harts Pilot Intervention for Veterans With Coronary Heart Disease (VHPI)
12. juni 2018 opdateret af: VA Office of Research and Development
Representational Telehealth Nursing Intervention for Veterans With CHD
The purpose of this research study is to survey patients to learn about their beliefs and behaviors related to the management of heart disease and to discuss options for making healthy lifestyle changes.
From the information the investigators get from patients, the investigators hope to develop better methods for taking care of patients who have heart disease.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Coronary heart disease (CHD) is a significant health threat among veterans.
Compared to their civilian counterparts, veterans experience greater disability, reinfarction, and mortality following myocardial infarction (MI) and other acute coronary syndromes (ACS).
High rates of hypertension, diabetes, and cardiac risk behaviors (e.g., smoking) and low socioeconomic status (SES) further increase veterans' CHD-related morbidity and mortality.
The proposed pilot project will establish the feasibility of a telehealth nursing intervention for veterans with CHD who are recovering from MI/ACS.
The Veterans Heart Attack Representations Telehealth (Vet-HART) intervention is designed to promote adaptive conceptual change in veterans' beliefs (common sense models or representations) about CHD etiology and self-management and facilitate health behavior changes (e.g., smoking cessation, medication adherence, diet management, and increased physical activity).
The long-term goal of this research program is to improve veterans' quality of life (QoL) and reduce their CHD-related morbidity/mortality.
The proposed project is the requisite next step in attaining that goal.
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
12
Fase
- Fase 2
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Iowa
-
Iowa City, Iowa, Forenede Stater, 52246-2208
- Iowa City VA Health Care System, Iowa City, IA
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år og ældre (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- Admission to an inpatient medicine unit for MI, ACS, and coronary angiography
- Age
Exclusion Criteria:
- Altered mental status
- Language barriers
- Dementia or Cognitive Impairment
- Diagnostic Study
- Resident in long-term care facility prior to the present admission
- Planned discharge to a skilled or intermediate care facility or hospice
- Lack of access to a functioning phone
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Dobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Eksperimentel: Motivational Interview
For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention.
The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes.
|
For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention.
The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes.
|
Ingen indgriben: Usual Care
For those randomly assigned to the usual care group, they will receive standard-of-care by their regular primary care provider.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
SF-36v Physical Function Scale
Tidsramme: Change from baseline to 3-months post hospital discharge
|
Physical Functioning Subscale from the SF-36v.
Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.
|
Change from baseline to 3-months post hospital discharge
|
SF-36v Role Limitations Due to Physical Health Scale
Tidsramme: Change from baseline to 3-months post hospital discharge
|
Role Limitations Due to Physical Health Subscale from the SF-36v.
Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.
|
Change from baseline to 3-months post hospital discharge
|
SF-36v Role Limitations Due to Emotional Problems Scale
Tidsramme: Change from baseline to 3-months post hospital discharge
|
Role Limitations Due to Emotional Problems Scale from the SF-36v.
Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.
|
Change from baseline to 3-months post hospital discharge
|
SF-36v Energy-Fatigue Scale
Tidsramme: Change from baseline to 3-months post hospital discharge
|
Energy-Fatigue Subscale from the SF-36v.
Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.
|
Change from baseline to 3-months post hospital discharge
|
SF-36v Emotional Well-Being Scale
Tidsramme: Change from baseline to 3-months post hospital discharge
|
Emotional Well-Being Subscale from the SF-36v.
Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.
|
Change from baseline to 3-months post hospital discharge
|
SF-36v Social Functioning Scale
Tidsramme: Change from baseline to 3-months post hospital discharge
|
Social Functioning Subscale from the SF-36v.
Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.
|
Change from baseline to 3-months post hospital discharge
|
SF-36v Pain Scale
Tidsramme: Change from baseline to 3-months post hospital discharge
|
Pain Subscale from the SF-36v.
Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.
|
Change from baseline to 3-months post hospital discharge
|
SF-36v General Health Scale
Tidsramme: Change from baseline to 3-months post hospital discharge
|
General Health Subscale from the SF-36v.
Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.
|
Change from baseline to 3-months post hospital discharge
|
Seattle Angina Questionnaire Physical Limitations Scale
Tidsramme: Change from baseline to 3-months post hospital discharge
|
Physical Limitations Subscale from the Seattle Angina Questionnaire.
Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.
|
Change from baseline to 3-months post hospital discharge
|
Seattle Angina Questionnaire Angina Stability Scale
Tidsramme: Change from baseline to 3-months post hospital discharge
|
Angina Stability Subscale from the Seattle Angina Questionnaire.
Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.
|
Change from baseline to 3-months post hospital discharge
|
Seattle Angina Questionnaire Angina Frequency Scale
Tidsramme: Change from baseline to 3-months post hospital discharge
|
Angina Frequency Subscale from the Seattle Angina Questionnaire.
Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.
|
Change from baseline to 3-months post hospital discharge
|
Seattle Angina Questionnaire Treatment Satisfaction Scale
Tidsramme: Change from baseline to 3-months post hospital discharge
|
Treatment Satisfaction Subscale from the Seattle Angina Questionnaire.
Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.
|
Change from baseline to 3-months post hospital discharge
|
Seattle Angina Questionnaire Disease Perception Scale
Tidsramme: Change from baseline to 3-months post hospital discharge
|
Disease Perception Subscale from the Seattle Angina Questionnaire.
Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.
|
Change from baseline to 3-months post hospital discharge
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Mark W Vander Weg, PhD MS BA, Iowa City VA Health Care System, Iowa City, IA
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
30. april 2012
Primær færdiggørelse (Faktiske)
30. juni 2012
Studieafslutning (Faktiske)
31. oktober 2012
Datoer for studieregistrering
Først indsendt
19. marts 2012
Først indsendt, der opfyldte QC-kriterier
26. marts 2012
Først opslået (Skøn)
29. marts 2012
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
24. december 2018
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
12. juni 2018
Sidst verificeret
1. juni 2018
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- PPO 09-283
- 200910778 (Anden identifikator: University of Iowa)
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Hjerte sygdom
-
Region SkaneTilmelding efter invitationHjertesvigt New York Heart Association (NYHA) klasse II | Hjertesvigt New York Heart Association (NYHA) klasse IIISverige
-
Medical University of BialystokInstitute of Cardiology, Warsaw, Poland; Medical University of Lodz; Poznan... og andre samarbejdspartnereIkke rekrutterer endnuHjertesvigt, systolisk | Hjertesvigt med reduceret udstødningsfraktion | Hjertesvigt New York Heart Association Klasse IV | Hjertesvigt New York Heart Association Klasse IIIPolen
-
University of WashingtonAmerican Heart AssociationAfsluttetHjertesvigt, Kongestiv | Mitokondriel ændring | Hjertesvigt New York Heart Association Klasse IVForenede Stater
-
Novartis PharmaceuticalsAfsluttetPatienter, der med succes afslutter den 12-måneders behandlingsperiode i kernestudiet (de Novo Heart-modtagere), som var interesserede i at blive behandlet med EC-MPS
-
University Hospital, GasthuisbergUkendtTransient Left Ventricular Ballooning SyndromeBelgien
-
NYU Langone HealthRekrutteringTako-tsubo kardiomyopati | Takotsubo kardiomyopati | Broken Heart SyndromeForenede Stater
-
French Cardiology SocietyAfsluttet
Kliniske forsøg med Motivational Interview
-
Penn Medicine Princeton HealthUkendtVægttabForenede Stater
-
The Cleveland ClinicAmerican Academy of Sleep MedicineRekrutteringObstruktiv søvnapnø | Akut dekompenseret hjertesvigt | Motiverende forbedring | PAP OverholdelseForenede Stater
-
University of North Carolina, Chapel HillNational Institute on Drug Abuse (NIDA); National Institute of Mental Health...Afsluttet
-
UConn HealthNational Institute on Drug Abuse (NIDA)Afsluttet
-
Dartmouth-Hitchcock Medical CenterNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Afsluttet
-
Assistance Publique - Hôpitaux de ParisNational Cancer Institute, FranceAfsluttetKræft | Ældre | Etnografisk interview | Social repræsentation af at være ældre | Årsager til ikke-deltagelse i kliniske forsøg | Kvalitativ metodeFrankrig
-
University of North Carolina, Chapel HillNational Institute on Drug Abuse (NIDA); National Institute on Alcohol... og andre samarbejdspartnereAfsluttet
-
Beth Israel Deaconess Medical CenterAfsluttetDyspepsi | Halsbrand | Gastroøsofageal reflukssygdom (GERD)Forenede Stater
-
Northwestern UniversityRegeneron PharmaceuticalsAfsluttetPsoriasis | Atopisk dermatitis | IktyoseForenede Stater
-
UConn HealthDonaghue Medical Research FoundationAfsluttet